Why is Kopran falling/rising?

As of 26-Sep, Kopran Ltd's stock price is currently at Rs 173.55, reflecting a decline of Rs 7.25 or 4.01%. The stock has been underperforming, having fallen for the last two days with a total drop of 5.06% during this period. Today's performance indicates that it has underperformed its sector by 1.67%, and it reached an intraday low of Rs 171.9. Over the past week, the stock has shown a slight increase of 0.38%, but it has significantly underperformed over the past year with a return of -49.10%. The company has reported negative results for the last four consecutive quarters, with a notable decline in net sales and profits, which has contributed to the stock's poor performance and investor sentiment.
In the broader market context, the Sensex has experienced a decline of 2.66% over the past week, indicating a challenging environment for stocks in general. However, Kopran's recent performance is particularly concerning as it has not only underperformed the benchmark but also the pharmaceutical sector, which has fallen by 2.34%. The company's low debt-to-EBITDA ratio and attractive valuation metrics are overshadowed by its poor long-term growth prospects and declining sales, leading to a lack of confidence from investors, as evidenced by the minimal holdings from domestic mutual funds. Overall, the combination of negative financial results and broader market challenges has resulted in the stock's downward movement.